TNF inhibitor
The Annual Review of Best ACR 2020 abstracts featuring Drs. Cush and Kavanaugh filmed on the last day of Virtual ACR 2020 Nov. 9, 2020.
Dr. Kevin Winthrop reviews all things COVID-related including abstract L01, steroids and DMARDs, vaccination status - and how long this pandemic will last.
Dr. Lianne Gensler reviews several SpA abstracts and a session on MRI presented at the 2020 ACR annual meeting. Abstracts reviews: abstract #1883, #2014, #L11 and #2022.
Janet Pope Janetbirdope
Richard Conway RichardPAConway
Robert B Chao, MD doctorRBC
Upadacitinib vs. Adalimumab vs. PBO in PsA Phase 3 RCT ⬇️MSK symptoms, PsO, function, pain, fatigue, rads progression in UPA *⃣UPA15 non-inferior to ADA for ACR20, UPA30 superior *⃣Similar VTE in all arms @RheumNow #ACR20 Abs#2026 https://t.co/OHzIjXKqAu
Eric Dein ejdein1
Dr. John Cush RheumNow
European Rheum Consortium (SHARE) recommendations for Rx of systemic JIA: 1) Systemic JIA - AOSD; 2) STEROIDs, 3) IL-1 inhibitors; 4) TCZ, 5) MTX & TNFi mainly for arthritis. Should be aware of risk for MAS and ILD #ACR20 Abstr#1148 https://t.co/mgZvLKNljs
Dr. John Cush RheumNow
Network Meta-Analysis of JAK and TNF Inhib in 19 AS studies (3,654pts) showed best results with TNFi (golimumab and infliximab) but JAKs also appear to be effective option. #ACR20 Abstr#1357 #UTSW @AdelaCastro222 https://t.co/HnnPD6eXW5 https://t.co/Li30kkp3P1
ACR21 Podcasts
Believing Is Doing (1.21.2022)Jan 21, 2022- The Overpricing Of Drugs (1.14.2022)Jan 14, 2022
Comorbidities in axSpA- A Focus on Cardiovascular Features Sponsored by Novartis Medical AffairsJan 10, 2022- 2021 Rheumatology Year in Review (1.7.2022)Jan 07, 2022
- Best of 2021 -Jack of All Subspecialties (12.31.2021)Dec 31, 2021
